用抗体药物偶联物靶向 Merkel 细胞癌的 CD56。
Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma.
机构信息
Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-BioCenter 1, Vienna, 1030, Austria.
Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, 1030, Austria.
出版信息
Br J Dermatol. 2022 Feb;186(2):209-210. doi: 10.1111/bjd.20894. Epub 2021 Nov 24.
Abstract
Esnault . 2022; 186:295–306.
摘要
埃斯努. 2022 年；186 卷：295–306 页。
相似文献
1
Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma.用抗体药物偶联物靶向 Merkel 细胞癌的 CD56。
Br J Dermatol. 2022 Feb;186(2):209-210. doi: 10.1111/bjd.20894. Epub 2021 Nov 24.
2
Merkel cell carcinoma in a child.儿童 Merkel 细胞癌
J Pediatr Hematol Oncol. 2009 May;31(5):359-61. doi: 10.1097/MPH.0b013e3181984f6b.
3
Case 19-2008: Merkel-cell carcinoma.病例19 - 2008：默克尔细胞癌。
N Engl J Med. 2008 Oct 9;359(15):1629-30; author reply 1630-1. doi: 10.1056/NEJMc081499.
4
PD-1 inhibition in advanced Merkel-cell carcinoma.晚期默克尔细胞癌中的程序性死亡受体1（PD-1）抑制作用
Lancet Oncol. 2016 Jun;17(6):e225. doi: 10.1016/S1470-2045(16)30112-7. Epub 2016 Apr 28.
5
Overview of Merkel cell carcinoma and recent advances in research.默克尔细胞癌概述及研究新进展
Int J Dermatol. 2003 Sep;42(9):749-51. doi: 10.1046/j.1365-4362.2003.01913.x.
6
From genetic characterization to new potential therapeutic options: targeting Bcl-xL in Merkel carcinoma.从基因特征分析到新的潜在治疗选择：默克尔细胞癌中靶向Bcl-xL蛋白
Br J Dermatol. 2023 Jul 7;189(1):7. doi: 10.1093/bjd/ljad150.
7
Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.同时发生的转移性黑色素瘤和默克尔细胞癌经派姆单抗治疗后完全缓解
Acta Derm Venereol. 2017 Nov 15;97(10):1252-1254. doi: 10.2340/00015555-2757.
8
Adcitmer , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.阿昔替尼，一种新型 CD56 靶向单甲基澳瑞他汀 E 偶联抗体，是一种治疗 Merkel 细胞癌的潜在治疗方法。
Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770. Epub 2021 Nov 2.
9
Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus.在两名默克尔细胞多瘤病毒阳性的默克尔细胞癌患者中使用α干扰素。
Acta Oncol. 2011 Apr;50(3):479-80. doi: 10.3109/0284186X.2010.512924. Epub 2010 Sep 9.
10
In brief: Avelumab (Bavencio) for metastatic merkel cell carcinoma.简而言之：阿维鲁单抗（巴文西奥）用于治疗转移性默克尔细胞癌。
Med Lett Drugs Ther. 2017 Jul 17;59(1521):e120.
引用本文的文献
1
Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models.默克尔细胞癌：肿瘤生物学的最新进展、新兴疗法及临床前模型
Front Oncol. 2024 Jul 29;14:1413793. doi: 10.3389/fonc.2024.1413793. eCollection 2024.
2
Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma.动态阈值和组织解离优化 CITE-seq 鉴定转移性黑色素瘤中表面蛋白丰度的差异。
Commun Biol. 2023 Aug 10;6(1):830. doi: 10.1038/s42003-023-05182-6.
本文引用的文献
1
Adcitmer , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.阿昔替尼，一种新型 CD56 靶向单甲基澳瑞他汀 E 偶联抗体，是一种治疗 Merkel 细胞癌的潜在治疗方法。
Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770. Epub 2021 Nov 2.
2
Unlocking the potential of antibody-drug conjugates for cancer therapy.解锁抗体药物偶联物在癌症治疗中的潜力。
Nat Rev Clin Oncol. 2021 Jun;18(6):327-344. doi: 10.1038/s41571-021-00470-8. Epub 2021 Feb 8.
3
LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma.赖氨酸特异性去甲基化酶1（LSD1）抑制可诱导默克尔细胞癌发生分化和细胞死亡。
EMBO Mol Med. 2020 Nov 6;12(11):e12525. doi: 10.15252/emmm.202012525. Epub 2020 Oct 7.
4
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program.avelumab 治疗转移性 Merkel 细胞癌患者的疗效和安全性：来自全球扩大准入计划的经验。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000313.
5
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.接受派姆单抗作为一线治疗的晚期 Merkel 细胞癌患者的持久肿瘤消退和总生存期。
J Clin Oncol. 2019 Mar 20;37(9):693-702. doi: 10.1200/JCO.18.01896. Epub 2019 Feb 6.
6
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities.默克尔细胞癌的生物学和治疗：当前的认识和研究重点。
Nat Rev Clin Oncol. 2018 Dec;15(12):763-776. doi: 10.1038/s41571-018-0103-2.
7
Merkel cell carcinoma.默克尔细胞癌。
Nat Rev Dis Primers. 2017 Oct 26;3:17077. doi: 10.1038/nrdp.2017.77.
8
CD56 in the Immune System: More Than a Marker for Cytotoxicity?免疫系统中的CD56：不仅仅是细胞毒性的标志物？
Front Immunol. 2017 Jul 24;8:892. doi: 10.3389/fimmu.2017.00892. eCollection 2017.
9
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.默克尔细胞癌的辅助放疗和化疗：来自国家癌症数据库的6908例病例的生存分析
J Natl Cancer Inst. 2016 May 31;108(9). doi: 10.1093/jnci/djw042. Print 2016 Sep.
Zotero 插件